Silencing MCL1 (but not BCL2L1 (bcl-xL)) induced cell death in a subset of triple negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC) cell lines and was correlated with the expression of the various BCL2 family members [12–14]. This evidence concerns the gene BCL2L1 and triple-negative breast carcinoma.